U.S. Specialized REITs Stock News

If you are wondering whether Stryker at around $353 a share is attractively valued or whether the market has already priced in its strengths, you are in the right place to unpack what the current valuation really implies. The stock is roughly flat in the short term, down 0.3% over the last week and 3.1% over the last month. However, it still reflects solid longer term gains of 49.8% over 3 years and 56.9% over 5 years. Recent headlines have focused on Stryker expanding its medical technology...

We wouldn't blame Energy Services of America Corporation ( NASDAQ:ESOA ) shareholders if they were a little worried...

If you are wondering whether CubeSmart is quietly turning into a value opportunity while the market looks the other way, this breakdown will help you consider whether the current price really makes sense. The stock has drifted lower this year, with the share price at $35.95, down 13.6% year to date and 11.4% over the last 12 months, although it remains up 31.5% over five years. Recently, investors have been weighing the outlook for storage demand and interest rates, which has kept sentiment...

Hilton Worldwide Holdings (HLT) just hit a fresh 52 week high after announcing new Canopy by Hilton openings in Türkiye and issuing $1 billion in senior notes to streamline its balance sheet. See our latest analysis for Hilton Worldwide Holdings. That mix of fresh Canopy openings and balance sheet cleanup comes on top of a strong run, with the share price up around the mid-teens over the past year and multi year total shareholder returns firmly signaling building momentum rather than a late...

Norwegian Cruise Line Holdings (NCLH) has been quietly drifting higher, with the stock up roughly 22% over the past month, even as its past 3 months performance remains in the red. See our latest analysis for Norwegian Cruise Line Holdings. Zooming out, that 1 month share price return of about 22% is a sharp bounce against a weaker year to date share price return and a negative 1 year total shareholder return. Together these suggest momentum is rebuilding as investors reprice cruising demand...

Wondering if Modine Manufacturing is still a smart buy after its huge run up, or if the easy money has already been made? You are not alone. This article will unpack whether the current price still stacks up against the fundamentals. The stock has cooled off recently, slipping about 4.3% over the last week and 5.4% over the past month. It is still up 15.3% year to date and 581.9% over three years and 1000.4% over five years. Those kinds of multi year gains often come after the market wakes...

Applied Industrial Technologies (AIT) just doubled down on its growth strategy by closing acquisitions of IRIS Factory Automation and Hydradyne, while also rolling out richer shareholder returns through higher dividends and a fresh share repurchase program. See our latest analysis for Applied Industrial Technologies. Those moves are landing against a solid backdrop, with the latest share price of $259.48 sitting on an 8.75 percent year to date share price return and an impressive 5 year total...

Over the past week, Reddit has attracted fresh attention as analysts praised its growing user base, AI-driven advertising tools, and expanding role as a data source for training AI models, while updated inflation data supported sentiment toward fast-growing tech platforms. At the same time, a substantial insider share sale and increasing emphasis on monetizing Reddit’s human-generated data added new angles for investors assessing how the business converts engagement into cash flow. We’ll now...

Circle Internet Group (CRCL) has quietly outperformed over the past month, climbing about 16% even as its past 3 months remain sharply negative. This setup has traders reassessing its long term stablecoin story. See our latest analysis for Circle Internet Group. The recent rebound, including a roughly 16% 30 day share price return after a weak 90 day patch, suggests sentiment toward Circle’s stablecoin strategy is stabilizing even as the year to date share price performance still looks...

Earlier in 2025, the California Public Utilities Commission voted 4–1 to let San Diego Gas & Electric and Southern California Gas, owned by Sempra, keep allowed profit margins around 10% for 2026, despite pressure from consumer advocates for much lower levels. This decision shores up visibility on future returns for Sempra’s California utilities while highlighting ongoing political tension over energy affordability and utility profitability. We’ll now examine how securing roughly 10% allowed...

Sociedad Química y Minera de Chile recently returned to profitability with US$407.8 million in net income for the nine months to September 30, 2025, completed a US$125.7 million acquisition of Sichuan Dixin’s 20,000‑ton lithium hydroxide plant, and agreed a new profit‑sharing joint venture with Codelco over the Salar de Atacama. China’s revocation of multiple lithium mining licenses has tightened supply and pushed local prices higher, which enhances the importance of SQM’s low‑cost global...

In the past week, RingCentral reported quarterly revenue of US$638.7 million, growing 4.9% year on year and meeting analyst expectations, but issued revenue guidance for the next quarter that fell well short of forecasts. While management highlighted solid execution, expanding margins, and strong free cash flow, the weaker forward guidance raised fresh questions about the pace of RingCentral’s growth as AI-related investment and competition intensify. Next, we’ll explore how RingCentral’s...

If you are wondering whether Lam Research is still worth buying after its huge run, you are not alone. This breakdown will help you cut through the noise. The stock has climbed 2.6% over the last week, 10.7% over the past month, and is up an eye catching 127.4% year to date. It has recorded a staggering 131.5% gain over 1 year and 312.4% over 3 years, which hints at strong momentum but also rising expectations. Recently, Lam has stayed in the spotlight as investors double down on chip...

If you are wondering whether EchoStar’s explosive run still has room to continue, or if the market has already priced in the story, you are not alone. This is exactly where a closer look at valuation comes in. After a massive 350.9% year to date gain and 353.7% rise over the last year, the stock has recently cooled off a bit, with a 1.7% pullback over the past week. This could signal either a healthy breather or early profit taking. Recent headlines have focused on EchoStar’s strategic...

Earlier this week, Skyward Specialty Insurance Group, Inc. and AI underwriting firm Sixfold announced a partnership to accelerate AI-powered underwriting across Skyward’s U.S. property and casualty lines, with Sixfold’s platform already deployed in six business units and more than 10 product lines. The rapid 8–10 week rollout timeline and broad deployment underscore how quickly Skyward is embedding AI into core underwriting workflows to enhance data-driven decisions and efficiency. We’ll now...

In mid-December 2025, Yelp’s Chief Financial Officer David Schwarzbach sold 13,500 company shares, adding to a year-long pattern of insider sales with no corresponding insider purchases. This steady stream of insider selling activity may influence how investors interpret leadership confidence in Yelp’s prospects, especially alongside mixed operational signals. We’ll now examine how this pattern of insider selling could influence Yelp’s existing investment narrative and the way investors...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

MiMedx Group recently published new peer-reviewed data in the Journal of Inflammation showing that its Purion-processed DHACM and LHACM placental allografts exert multifactorial immunomodulatory effects on key inflammatory cells involved in wound healing. The findings that these allografts both temper inflammatory monocyte and macrophage activity and enhance pro-reparative functions such as efferocytosis and cell survival could strengthen the medical community’s confidence in MiMedx’s...

PAR Technology (PAR) is back in the spotlight after Wasatch Global Investors exited its position, citing weaker than expected organic growth, just as the company leans on new products like Smart Passes to reset its story. See our latest analysis for PAR Technology. That backdrop helps explain why, even with a recent 1 month share price return of about 8 percent and a 1 day gain of nearly 3 percent to 36.83 dollars, PAR’s year to date share price return is still deep in the red. Its 1 year...

GoDaddy (GDDY) has quietly slipped this year, with the stock down around 36% year to date despite solid revenue and earnings growth, and that disconnect is exactly what has investors rechecking their assumptions. See our latest analysis for GoDaddy. Despite the drop, the 1 day and 7 day share price returns have turned positive, and that small change in tone sits against a still healthy three year total shareholder return of nearly 70%. This suggests long term holders have been well rewarded...

If you have been wondering whether KBR is a beaten down opportunity or a value trap, you are not alone. This article is going to walk through the numbers with you. After sliding to around $42.80, the stock is down 1.6% over the last week and up 5.7% over 30 days, but still sitting on a heavy year-to-date loss of 26.1% and a 23.9% drop over the past year, despite being up 51.8% over five years. That kind of whiplash performance has come alongside a steady stream of contract wins and strategic...

In recent coverage, Mizuho and Citi both initiated positive ratings on Spyre Therapeutics, highlighting its half-life extended monoclonal antibody pipeline for inflammatory bowel and other autoimmune diseases. Analysts emphasized Spyre’s ability to explore novel antibody combinations and its rheumatic disease program, with several firms now expressing broad confidence in the company’s development approach. We’ll now explore how this wave of optimistic analyst coverage, particularly around...

Expand Energy (EXE) just released a standout earnings update, with adjusted EPS jumping sharply year over year on stronger oil, gas, and NGL sales, plus sizable contributions from marketing and derivatives. See our latest analysis for Expand Energy. Even after this blowout quarter, the stock has cooled off recently, with a 30 day share price return of minus 8.1 percent. However, a 1 year total shareholder return of 17.2 percent still signals that momentum is building over the longer run. If...

HeartFlow (HTFL) has climbed about 9% in a day and 8% over the past week, an eye catching move for a relatively young medtech stock. Investors are asking whether this momentum is sustainable. See our latest analysis for HeartFlow. The latest surge comes after a choppy few months, with a 30 day share price return of 5.21% but a 90 day share price return still in negative territory, suggesting momentum is only just starting to rebuild. If HeartFlow's recent move has your attention, it could be...